Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
23-25 May, 2025
Not Confirmed
Not Confirmed
26-27 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
23-25 May, 2025
Industry Trade Show
Not Confirmed
26-27 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
08 Nov 2022
// ACCESSWIRE
https://www.accesswire.com/724555/Allysta-Pharmaceuticals-Inc-Announces-Completion-of-Enrollment-in-Phase-2b3-Clinical-Trial-OASIS-1-Evaluating-the-Efficacy-and-Safety-of-ALY688-Ophthalmic-Solution-in-Dry-Eye-Disease
22 Jun 2021
// ACCESSWIRE
https://www.accesswire.com/652578/Allysta-Pharmaceuticals-Inc-Announces-Initiation-of-Dosing-in-OASIS-1-Phase-2b3-Clinical-Trial-ALY688-301-Study-Evaluating-the-Efficacy-and-Safety-of-ALY688-Ophthalmic-Solution-in-Dry-Eye
10 Jun 2021
// ACCESSWIRE
https://www.accesswire.com/651136/Allysta-Pharmaceuticals-Inc-Announces-Start-of-Phase-1-Clinical-Trial-of-ALY688-SR-a-Novel-First-in-Class-Peptide-that-Targets-Adiponectin-Signaling
16 Dec 2020
// ACCESSWIRE
https://www.accesswire.com/620848/Allysta-Pharmaceuticals-Inc-Announces-Positive-Preclinical-Data-in-a-NASH-Model-Demonstrating-its-Adiponectin-Analogue-ALY688-Reduces-Liver-Fat-Inflammation-and-Fibrosis
01 Dec 2020
// ACCESSWIRE
https://www.accesswire.com/618835/Allysta-Pharmaceuticals-Inc-Announces-Positive-Results-from-its-Phase-12a-Clinical-Trial-of-ALY688-Ophthalmic-Solution-in-Dry-Eye-Disease
08 Jan 2020
// PRESS RELEASE
ABOUT THIS PAGE